Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

Fingerprint

???publication_fingerprints_help???

Pharmacology, Toxicology and Pharmaceutical Science

100
Colorectal Carcinom... Pharmacology, Toxicology ...
100
Oxaliplatin Pharmacology, Toxicology ...
100
Polo Like Kinase 1 Pharmacology, Toxicology ...
11
Drug Resistance Pharmacology, Toxicology ...
11
Malignant Neoplasm Pharmacology, Toxicology ...
11
Neoplasm Pharmacology, Toxicology ...
11
Chemotherapy Pharmacology, Toxicology ...
11
Recurrent Disease Pharmacology, Toxicology ...
11
Cancer Model Pharmacology, Toxicology ...

Biochemistry, Genetics and Molecular Biology

100
Cell Cycle Biochemistry, Genetics an...
100
Polo-Like Kinase 1 Biochemistry, Genetics an...
11
Drug Resistance Biochemistry, Genetics an...
11
Genetics Biochemistry, Genetics an...
11
Genome Instability Biochemistry, Genetics an...
11
Transcriptomics Biochemistry, Genetics an...
11
Cancer Model Biochemistry, Genetics an...

Medicine and Dentistry

100
Cell Cycle Medicine and Dentistry
100
Oxaliplatin Medicine and Dentistry
100
Polo Like Kinase 1 Medicine and Dentistry
100
Colorectal Carcinom... Medicine and Dentistry
11
Neoplasm Medicine and Dentistry
11
In Vitro Medicine and Dentistry
11
Drug Resistance Medicine and Dentistry
11
Malignant Neoplasm Medicine and Dentistry
11
Recurrent Disease Medicine and Dentistry
11
Genomic Instability Medicine and Dentistry
11
Transcriptomics Medicine and Dentistry
11
Cancer Model Medicine and Dentistry
Research OutputsResearch Output authored by Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer is tagged with the concept